Safety and Effectiveness of Same-Day Chlamydia trachomatis and Neisseria gonorrhoeae Screening and Treatment Among Gay, Bisexual, Transgender, and Homeless Youth in Los Angeles, California, and New Orleans, Louisiana.
Adolescent
Ambulatory Care Facilities
Child
Chlamydia Infections
/ diagnosis
Chlamydia trachomatis
Delivery of Health Care
Female
Gonorrhea
/ diagnosis
Homeless Youth
/ statistics & numerical data
Homosexuality, Male
/ statistics & numerical data
Humans
Los Angeles
Male
Mass Screening
Neisseria gonorrhoeae
New Orleans
Point-of-Care Testing
Sexual and Gender Minorities
/ statistics & numerical data
Sexually Transmitted Diseases
/ drug therapy
Time Factors
Transgender Persons
/ statistics & numerical data
Young Adult
Journal
Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
7
11
2019
medline:
21
11
2020
entrez:
6
11
2019
Statut:
ppublish
Résumé
Gay, bisexual, transgender, and homeless youth are at risk of sexually transmitted infections. As part of an adolescent human immunodeficiency virus prevention study, we provided same-day Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing and treatment. We aimed to evaluate the feasibility and effectiveness of same-day CT and NG treatment on the proportion of participants receiving timely treatment. We recruited adolescents with high sexual risk behaviors aged 12 to 24 years from homeless shelters, lesbian, gay, bisexual, and transgender organizations, and community health centers in Los Angeles, California, and New Orleans, Louisiana from May 2017 to June 2019. Initially, participants were offered point-of-care pharyngeal, rectal, and urethral/vaginal CT and NG testing and referral to another clinic for treatment. After March 2018 in Los Angeles and November 2018 in New Orleans, we provided same-day treatment (and partner treatment packs) for study participants. We measured the proportion of participants who received same-day treatment and the median time to treatment. We collected frequency of partner treatment and any reported adverse treatment-related events. The proportion of participants receiving same-day CT and NG treatment increased from 3.6% (5/140) to 21.1% (20/95; Δ17.5%; 95% confidence interval, 9.2%-26.9%) after implementation of same-day testing and treatment. The median time to treatment decreased from 18.5 to 3 days. Overall, 36 participants took a total of 48 partner treatment packs. There were no reported treatment-related adverse events. Providing sexually transmitted infection treatment to adolescents at the same visit as testing is feasible and safe, and can increase the proportion of individuals receiving timely treatment.
Sections du résumé
BACKGROUND
Gay, bisexual, transgender, and homeless youth are at risk of sexually transmitted infections. As part of an adolescent human immunodeficiency virus prevention study, we provided same-day Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing and treatment. We aimed to evaluate the feasibility and effectiveness of same-day CT and NG treatment on the proportion of participants receiving timely treatment.
METHODS
We recruited adolescents with high sexual risk behaviors aged 12 to 24 years from homeless shelters, lesbian, gay, bisexual, and transgender organizations, and community health centers in Los Angeles, California, and New Orleans, Louisiana from May 2017 to June 2019. Initially, participants were offered point-of-care pharyngeal, rectal, and urethral/vaginal CT and NG testing and referral to another clinic for treatment. After March 2018 in Los Angeles and November 2018 in New Orleans, we provided same-day treatment (and partner treatment packs) for study participants. We measured the proportion of participants who received same-day treatment and the median time to treatment. We collected frequency of partner treatment and any reported adverse treatment-related events.
RESULTS
The proportion of participants receiving same-day CT and NG treatment increased from 3.6% (5/140) to 21.1% (20/95; Δ17.5%; 95% confidence interval, 9.2%-26.9%) after implementation of same-day testing and treatment. The median time to treatment decreased from 18.5 to 3 days. Overall, 36 participants took a total of 48 partner treatment packs. There were no reported treatment-related adverse events.
CONCLUSIONS
Providing sexually transmitted infection treatment to adolescents at the same visit as testing is feasible and safe, and can increase the proportion of individuals receiving timely treatment.
Identifiants
pubmed: 31688719
doi: 10.1097/OLQ.0000000000001088
pmc: PMC6923576
mid: NIHMS1058690
pii: 00007435-202001000-00006
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
19-23Subventions
Organisme : NIMH NIH HHS
ID : P30 MH058107
Pays : United States
Organisme : NICHD NIH HHS
ID : U19 HD089886
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI028697
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Am J Emerg Med. 2012 Oct;30(8):1588-90
pubmed: 22169584
Sex Transm Dis. 2019 Jun;46(6):370-374
pubmed: 30817496
JMIR Res Protoc. 2018 Dec 14;7(12):e10777
pubmed: 30552083
Int J STD AIDS. 2018 Apr;29(5):474-482
pubmed: 29059032
MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):237-241
pubmed: 28278143
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
AIDS Educ Prev. 2006 Oct;18(5):444-60
pubmed: 17067255
Sex Transm Dis. 2011 Nov;38(11):1067-73
pubmed: 21992986
Infect Dis Obstet Gynecol. 2016;2016:4386127
pubmed: 27313440
J Clin Microbiol. 2013 Jun;51(6):1666-72
pubmed: 23467600
Sex Transm Dis. 2016 May;43(5):290-5
pubmed: 27100764
JAMA Pediatr. 2018 Dec 1;172(12):1117-1118
pubmed: 30326015
Sex Transm Infect. 2017 Jun;93(4):283
pubmed: 28576786
J Pediatr. 2017 Oct;189:48-53
pubmed: 28629687
Sex Transm Dis. 2017 Jul;44(7):398-400
pubmed: 28604481
JAMA Pediatr. 2019 Jul 1;173(7):695-697
pubmed: 31135829
JMIR Res Protoc. 2019 Jan 21;8(1):e10759
pubmed: 30664482
Sex Transm Dis. 2018 Oct;45(10):673-676
pubmed: 29528996
Am J Public Health. 2003 Jun;93(6):882-4
pubmed: 12773344
Pediatrics. 2012 Aug;130(2):e415-22
pubmed: 22753557
JMIR Res Protoc. 2019 Mar 22;8(3):e10795
pubmed: 30900994